Mirae Asset Global Investments Co. Ltd. Purchases 94,783 Shares of Tempus AI, Inc. $TEM

Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of Tempus AI, Inc. (NASDAQ:TEM) by 1,459.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 101,276 shares of the company’s stock after purchasing an additional 94,783 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Tempus AI were worth $8,174,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the business. Federated Hermes Inc. purchased a new stake in shares of Tempus AI during the 3rd quarter valued at about $632,000. Hussman Strategic Advisors Inc. bought a new stake in Tempus AI during the third quarter worth approximately $1,695,000. Belpointe Asset Management LLC purchased a new stake in Tempus AI during the third quarter valued at approximately $566,000. NWF Advisory Services Inc. bought a new stake in shares of Tempus AI in the 3rd quarter valued at approximately $906,000. Finally, Fortis Capital Advisors LLC bought a new stake in shares of Tempus AI in the 3rd quarter valued at approximately $566,000. Institutional investors own 24.22% of the company’s stock.

Wall Street Analysts Forecast Growth

TEM has been the topic of several analyst reports. TD Cowen downgraded Tempus AI from a “buy” rating to a “hold” rating in a research report on Tuesday, October 21st. HC Wainwright dropped their price objective on shares of Tempus AI from $98.00 to $89.00 and set a “buy” rating for the company in a research note on Friday, November 7th. BTIG Research increased their target price on shares of Tempus AI from $96.00 to $105.00 and gave the company a “buy” rating in a research note on Tuesday, November 25th. Needham & Company LLC raised their target price on shares of Tempus AI from $70.00 to $100.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Finally, Piper Sandler cut their price target on shares of Tempus AI from $105.00 to $80.00 and set a “neutral” rating on the stock in a report on Tuesday, November 11th. Six analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $87.20.

Insider Transactions at Tempus AI

In other Tempus AI news, COO Ryan Fukushima sold 10,099 shares of the company’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $65.54, for a total value of $661,888.46. Following the completion of the sale, the chief operating officer directly owned 829,081 shares in the company, valued at approximately $54,337,968.74. This represents a 1.20% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Andrew Polovin sold 12,874 shares of the firm’s stock in a transaction on Monday, November 24th. The shares were sold at an average price of $75.00, for a total value of $965,550.00. Following the transaction, the executive vice president owned 107,590 shares in the company, valued at approximately $8,069,250. This represents a 10.69% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 766,582 shares of company stock valued at $52,454,299. Company insiders own 26.27% of the company’s stock.

Tempus AI Stock Down 5.8%

Shares of TEM opened at $59.82 on Friday. The firm has a market capitalization of $10.64 billion, a P/E ratio of -50.27 and a beta of 5.22. Tempus AI, Inc. has a 12-month low of $36.22 and a 12-month high of $104.32. The firm has a fifty day moving average price of $68.56 and a 200-day moving average price of $74.02. The company has a current ratio of 3.28, a quick ratio of 3.12 and a debt-to-equity ratio of 2.45.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings data on Tuesday, November 4th. The company reported ($0.11) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.05. The company had revenue of $334.21 million during the quarter, compared to analyst estimates of $328.89 million. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. The firm’s revenue for the quarter was up 84.7% on a year-over-year basis. During the same quarter last year, the business posted ($0.46) EPS. Equities research analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.